Netherlands Diabetes Care Devices Market Outlook to 2016
Publisher Name » GlobalData
Published Date » 2010-05-10
No. Of Pages » 75
GlobalDatas medical equipment offering, Netherlands Diabetes Care Devices Market Outlook to 2016 provides key market data on the Netherlands diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Scope
- Market size and company share data for two diabetes care devices market categories Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.
- Data from 2002 to 2009, forecast forward for 7 years to 2016.
- 2009 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Netherlands diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Netherlands diabetes care devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and whats the most preferred mode of product distribution Identify, understand and capitalize.
Table Of Contents
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Netherlands 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Netherlands, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Netherlands, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Netherlands, Company Share (2008-2009) 20
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Netherlands, Overall Revenue ($m), 2002-2016 11
3.3 Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2009 12
3.4 Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2009 13
3.5 Diabetes Care Devices, Netherlands, Category Volume (Units), 2002-2016 17
3.6 Diabetes Care Devices, Netherlands, Company Share (2008-2009) 20
4 Glucose Monitoring In Netherlands 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Netherlands, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.4.1 Blood Glucose Meters Revenue (2002-2016) 27
4.5 Glucose Monitoring Overall Volume (2002-2016) 29
4.5.1 Blood Glucose Meters Volume (2002-2016) 31
4.6 Glucose Monitoring Average Price (2002-2016) 33
4.7 Glucose Monitoring Distribution Share (2008-2009) 34
4.8 Glucose Monitoring, Netherlands, Company Share (2008-2009) 35
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2009 23
4.3 Glucose Monitoring Market, Netherlands, Category Contribution (%), 2009 24
4.4 Glucose Monitoring Overall Revenue (2002-2016) 25
4.4.1 Blood Glucose Meters Revenue (2002-2016) 27
4.5 Glucose Monitoring Overall Volume (2002-2016) 29
4.5.1 Blood Glucose Meters Volume (2002-2016) 31
4.6 Glucose Monitoring Average Price (2002-2016) 33
4.7 Glucose Monitoring Distribution Share (2008-2009) 34
4.8 Glucose Monitoring, Netherlands, Company Share (2008-2009) 35
5 Insulin Delivery In Netherlands 37
5.1 Insulin Delivery, Market Segmentation 37
5.2 Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2009 38
5.3 Insulin Delivery Market, Netherlands, Category Contribution (%), 2009 39
5.4 Insulin Delivery Overall Revenue (2002-2016) 40
5.4.1 Insulin Pens Revenue (2002-2016) 43
5.5 Insulin Delivery Overall Volume (2002-2016) 45
5.5.1 Insulin Pens Volume (2002-2016) 47
5.6 Insulin Delivery Average Price (2002-2016) 49
5.7 Insulin Delivery Distribution Share (2008-2009) 50
5.8 Insulin Delivery, Netherlands, Company Share (2008-2009) 51
5.1 Insulin Delivery, Market Segmentation 37
5.2 Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2009 38
5.3 Insulin Delivery Market, Netherlands, Category Contribution (%), 2009 39
5.4 Insulin Delivery Overall Revenue (2002-2016) 40
5.4.1 Insulin Pens Revenue (2002-2016) 43
5.5 Insulin Delivery Overall Volume (2002-2016) 45
5.5.1 Insulin Pens Volume (2002-2016) 47
5.6 Insulin Delivery Average Price (2002-2016) 49
5.7 Insulin Delivery Distribution Share (2008-2009) 50
5.8 Insulin Delivery, Netherlands, Company Share (2008-2009) 51
6 Overview of Key Companies in Netherlands Diabetes Care Devices Market 53
6.1 F. Hoffmann-La Roche Ltd. 53
6.1.1 Company Overview 53
6.1.2 Share in the Netherlands Diabetes Care Devices Market 53
6.2 Sanofi-Aventis 54
6.2.1 Company Overview 54
6.2.2 Share in the Netherlands Diabetes Care Devices Market 54
6.3 Bayer HealthCare AG 55
6.3.1 Company Overview 55
6.3.2 Share in the Netherlands Diabetes Care Devices Market 55
6.4 Abbott Laboratories 56
6.4.1 Company Overview 56
6.4.2 Share in the Netherlands Diabetes Care Devices Market 56
6.5 LifeScan, Inc. 57
6.5.1 Company Overview 57
6.5.2 Share in the Netherlands Diabetes Care Devices Market 57
6.6 Eli Lilly and Company 58
6.6.1 Company Overview 58
6.6.2 Share in the Netherlands Diabetes Care Devices Market 58
6.7 Medtronic, Inc. 59
6.7.1 Company Overview 59
6.7.2 Share in the Netherlands Diabetes Care Devices Market 59
6.8 Novo Nordisk A/S 60
6.8.1 Company Overview 60
6.8.2 Share in the Netherlands Diabetes Care Devices Market 60
6.9 Becton, Dickinson and Company 61
6.9.1 Company Overview 61
6.10 Smiths Medical 61
6.10.1 Company Overview 61
6.11 B. Braun Melsungen AG 62
6.11.1 Company Overview 62
6.12 Terumo Corporation 62
6.12.1 Company Overview 62
6.13 ARKRAY, Inc. 63
6.13.1 Company Overview 63
6.14 Apex Biotechnology Corp. 63
6.14.1 Company Overview 63
6.15 Animas Corporation 63
6.15.1 Company Overview 63
6.16 Diabetes Management International BV 64
6.16.1 Company Overview 64
6.1 F. Hoffmann-La Roche Ltd. 53
6.1.1 Company Overview 53
6.1.2 Share in the Netherlands Diabetes Care Devices Market 53
6.2 Sanofi-Aventis 54
6.2.1 Company Overview 54
6.2.2 Share in the Netherlands Diabetes Care Devices Market 54
6.3 Bayer HealthCare AG 55
6.3.1 Company Overview 55
6.3.2 Share in the Netherlands Diabetes Care Devices Market 55
6.4 Abbott Laboratories 56
6.4.1 Company Overview 56
6.4.2 Share in the Netherlands Diabetes Care Devices Market 56
6.5 LifeScan, Inc. 57
6.5.1 Company Overview 57
6.5.2 Share in the Netherlands Diabetes Care Devices Market 57
6.6 Eli Lilly and Company 58
6.6.1 Company Overview 58
6.6.2 Share in the Netherlands Diabetes Care Devices Market 58
6.7 Medtronic, Inc. 59
6.7.1 Company Overview 59
6.7.2 Share in the Netherlands Diabetes Care Devices Market 59
6.8 Novo Nordisk A/S 60
6.8.1 Company Overview 60
6.8.2 Share in the Netherlands Diabetes Care Devices Market 60
6.9 Becton, Dickinson and Company 61
6.9.1 Company Overview 61
6.10 Smiths Medical 61
6.10.1 Company Overview 61
6.11 B. Braun Melsungen AG 62
6.11.1 Company Overview 62
6.12 Terumo Corporation 62
6.12.1 Company Overview 62
6.13 ARKRAY, Inc. 63
6.13.1 Company Overview 63
6.14 Apex Biotechnology Corp. 63
6.14.1 Company Overview 63
6.15 Animas Corporation 63
6.15.1 Company Overview 63
6.16 Diabetes Management International BV 64
6.16.1 Company Overview 64
7 Diabetes Care Devices Market Pipeline Products 65
8 Financial Deals Landscape 68
8.1 Partnerships 68
8.1.1 Insulet Enters Into Distribution Agreement with Ypsomed Holding 68
8.1 Partnerships 68
8.1.1 Insulet Enters Into Distribution Agreement with Ypsomed Holding 68
9 Appendix 69
9.1 Definitions of Markets Covered in the Report 70
9.1.1 Diabetes Care Devices 70
9.2 Research Methodology 72
9.3 Secondary Research 73
9.4 Primary Research 73
9.5 Models 74
9.6 Forecasts 74
9.7 Expert Panels 74
9.8 GlobalData Consulting 74
9.9 Currency Conversion 75
9.10 Contact Us 75
9.11 Disclaimer 75
9.1 Definitions of Markets Covered in the Report 70
9.1.1 Diabetes Care Devices 70
9.2 Research Methodology 72
9.3 Secondary Research 73
9.4 Primary Research 73
9.5 Models 74
9.6 Forecasts 74
9.7 Expert Panels 74
9.8 GlobalData Consulting 74
9.9 Currency Conversion 75
9.10 Contact Us 75
9.11 Disclaimer 75
List of Tables
Table 1: Diabetes Care Devices, Netherlands, Overall Revenue ($m), 2002-2016 11
Table 2: Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2009 13
Table 3: Diabetes Care Devices, Netherlands, Cross-Segment Analysis, 2002-2016 14
Table 4: Diabetes Care Devices, Netherlands, Overall Revenue ($m), Historic, 2002-2009 15
Table 5: Diabetes Care Devices, Netherlands, Overall Revenue ($m), Forecast, 2009-2016 16
Table 6: Diabetes Care Devices, Netherlands, Category Volume (Units), 2002-2016 17
Table 7: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2002-2009 18
Table 8: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2009-2016 19
Table 9: Diabetes Care Devices, Netherlands, Company Share by Revenue ($m), 2008-2009 21
Table 10: Glucose Monitoring Market, Netherlands, Category Contribution (%), 2009 24
Table 11: Glucose Monitoring, Netherlands, Revenue ($m) by Segment, Historic, 2002-2009 25
Table 12: Glucose Monitoring, Netherlands, Revenue ($m) by Segment, Forecast, 2009-2016 26
Table 13: Blood Glucose Meters, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2002-2009 27
Table 14: Blood Glucose Meters, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 28
Table 15: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2002-2009 29
Table 16: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2009-2016 30
Table 17: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2002-2009 31
Table 18: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2009-2016 32
Table 19: Glucose Monitoring, Netherlands, Average Price ($), Historic, 2002-2009 33
Table 20: Glucose Monitoring, Netherlands, Average Price ($), Forecast, 2009-2016 33
Table 21: Glucose Monitoring, Netherlands, Distribution Share by Revenue ($m), 2008-2009 34
Table 22: Glucose Monitoring, Netherlands, Company Share by Revenue ($m), 2008-2009 36
Table 23: Insulin Delivery Market, Netherlands, Category Contribution (%), 2009 39
Table 24: Insulin Delivery, Netherlands, Revenue ($m) by Segment, Historic, 2002-2009 41
Table 25: Insulin Delivery, Netherlands, Revenue ($m) by Segment, Forecast, 2009-2016 42
Table 26: Insulin Pens, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Table 27: Insulin Pens, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Table 28: Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2002-2009 45
Table 29: Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2009-2016 46
Table 30: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Table 31: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Table 32: Insulin Delivery, Netherlands, Average Price ($), Historic, 2002-2009 49
Table 33: Insulin Delivery, Netherlands, Average Price ($), Forecast, 2009-2016 49
Table 34: Insulin Delivery, Netherlands, Distribution Share by Revenue ($m), 2008-2009 50
Table 35: Insulin Delivery, Netherlands, Company Share by Revenue ($m), 2008-2009 52
Table 36: Diabetes Care Devices Pipeline Products 65
Table 37: Insulet Enters Into Distribution Agreement With Ypsomed Holding 68
Table 38: USD to Local Currency, Netherlands, Average Actual Rate 2002-2009 75
List of Figures
List of FiguresFigure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Netherlands, Overall Revenue ($m), 2002-2016 11
Figure 3: Diabetes Care Devices Market, Netherlands, Revenue Mix ($m), 2009 12
Figure 4: Diabetes Care Devices Market, Netherlands, Category Contribution (%), 2009 13
Figure 5: Diabetes Care Devices, Netherlands, Cross-Segment Analysis,2002-2016 14
Figure 6: Diabetes Care Devices, Netherlands, Overall Revenue ($m), Historic, 2002-2009 15
Figure 7: Diabetes Care Devices, Netherlands, Overall Revenue ($m), Forecast, 2009-2016 16
Figure 8: Diabetes Care Devices, Netherlands, Category Volume (Units), 2002-2016 17
Figure 9: Diabetes Care Devices, Netherlands, Category Volume (Units), Historic, 2002-2009 18
Figure 10: Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast, 2009-2016 19
Figure 11: Diabetes Care Devices, Netherlands, Company Share (%), 2009 20
Figure 12: Glucose Monitoring, Market Segmentation 22
Figure 13: Glucose Monitoring Market, Netherlands, Revenue Mix ($m), 2009 23
Figure 14: Glucose Monitoring Market, Netherlands, Category Contribution (%), 2009 24
Figure 15: Glucose Monitoring, Netherlands, Revenue ($m) by Segment, Historic, 2002-2009 25
Figure 16: Glucose Monitoring, Netherlands, Revenue ($m) by Segment, Forecast, 2009-2016 26
Figure 17: Blood Glucose Meters, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2002-2009 27
Figure 18: Blood Glucose Meters, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 28
Figure 19: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Historic, 2002-2009 29
Figure 20: Glucose Monitoring, Netherlands, Volume (Units) by Segment, Forecast, 2009-2016 30
Figure 21: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic, 2002-2009 31
Figure 22: Blood Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2009-2016 32
Figure 23: Glucose Monitoring, Netherlands, Company Share (%), 2009 35
Figure 24: Insulin Delivery, Market Segmentation 37
Figure 25: Insulin Delivery Market, Netherlands, Revenue Mix ($m), 2009 38
Figure 26: Insulin Delivery Market, Netherlands, Category Contribution (%), 2009 39
Figure 27: Insulin Delivery, Netherlands, Revenue ($m) by Segment, Historic, 2002-2009 40
Figure 28: Insulin Delivery, Netherlands, Revenue ($m) by Segment, Forecast, 2009-2016 42
Figure 29: Insulin Pens, Netherlands, Revenue ($m) by Sub-Segment, Historic, 2002-2009 43
Figure 30: Insulin Pens, Netherlands, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 44
Figure 31: Insulin Delivery, Netherlands, Volume (Units) by Segment, Historic, 2002-2009 45
Figure 32: Insulin Delivery, Netherlands, Volume (Units) by Segment, Forecast, 2009-2016 46
Figure 33: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic, 2002-2009 47
Figure 34: Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Forecast, 2009-2016 48
Figure 35: Insulin Delivery, Netherlands, Company Share (%), 2009 51
Figure 36: F. Hoffmann-La Roche Ltd, Company Share (%), Netherlands Diabetes Care Devices Market, 2009 53
Figure 37: Sanofi-Aventis, Company Share (%), Netherlands Diabetes Care Devices Market, 2009 54
Figure 38: Bayer HealthCare AG, Company Share (%), Netherlands Diabetes Care Devices Market, 2009 55
Figure 39: Abbott Laboratories, Company Share (%), Netherlands Diabetes Care Devices Market, 2009 56
Figure 40: LifeScan, Inc., Company Share (%), Netherlands Diabetes Care Devices Market, 2009 57
Figure 41: Eli Lilly and Company, Company Share (%), Netherlands Diabetes Care Devices Market, 2009 58
Figure 42: Medtronic, Inc., Company Share (%), Netherlands Diabetes Care Devices Market, 2009 59
Figure 43: Novo Nordisk A/S, Company Share (%),Netherlands Diabetes Care Devices Market, 2009 60
Figure 44: GlobalData Methodology 72
Upcoming Reports:
|
Wi-Fi Offload Equipment Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Wi-Fi has emerged as an important market driver for the mobile industry. In response to the dilemma of network traffic congestion, major mobile operators have publicly adopted Wi-Fi technology, but they are yet to implement its integration that will make Wi-Fi an extension to wireless mobile networks. This Wi-Fi offload is expected to offer traffic congestion relief and encourage users to choose Wi-Fi over cellular networks, thus distancing the subscriber from service providers. As a result, the future for Wi-Fi offload equipment market seems to be bright with the number of...
|
|
Disposable Gloves Market - Global Industry Size, Market Share, Trends, Analysis And Forecast 2011 - 2018
By - Transparency Market Research
Disposable gloves are used during medical examination and certain procedures and they prevent and protect medical personnel from different types of contamination. Disposable gloves are made of different types of material such as latex, nitrile, rubber, vinyl and neoprene. William Stewart Halsted was the first to use disposal medical gloves at the Johns Hopkins University in 1890. Most of the disposable gloves are classified depending upon the powered coat or non powered coat.
Disposable gloves market are finding increasing application in varied segments especially...
|
|
Nanofibers Technologies Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
Description
Nanofibers Technologies Market - Global Industry Analysis, Size, Share, Growth Nanofibers belong to the market of nanotechnology. They are fibers with diameters less than 100 nanometers. Most nanofibers are produced by electrospinning which is the most conventional method of production. Spinning biocomponent fiber is another emerging technique of nanofiber production. Some other nanofiber production methods include melt spinning, template synthesis, electroblowing, self-assembly, and forcespinning.
Most often the material used in nanofibers production...
|
Research Assistance
We will be happy to help you find what you need.
Please call us or write us:
Please call us or write us:
866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Email: sales@researchmoz.com
Select License type:
Share this report
Latest Reports
- The Future of the Haircare Market in Egypt to 2017
- The Future of the Haircare Market in Denmark to 2017
- Overview of international chemical market
- Russian market of microcredits and lending to SME in Russia
- Overview of furniture market
- The Future of the Haircare Market in Czech Republic to 2017
- LTE Strategy 2013 - 2018
- Natural And Synthetic (Ethoxyquin, BHA, BHT) Animal Feed Antioxidants Market For Swine, Poultry, Cattle And Aquaculture - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
- Seed Treatment Market (Insecticides, Fungicides, Other Chemical And Nonchemical Treatment) For Corn, Soybean, Wheat, Canola, Cotton And Others - Global Industry Analysis, Size, Share, Growth And Forecast, 2012 - 2018
- Future of the Spanish Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2018
Related News
|
One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
|
|
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples.
The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
|
|
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
|
|
Battling against flu, vaccination necessary for health workers
Sep 14, 2012
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease.
Health officials...
|
|
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...
|
